A new study by NYU Langone Health found a genetic link between GLP-1 use and increased risk of male-pattern hair loss. The study, published in the Journal of Investigative Dermatology, showed that men using GLP-1 medications for weight loss had a 7% added risk of losing their hair due to the medication
Researchers have found a potential side effect of GLP-1 receptor agonists used to treat type 2 diabetes: an increased risk of non-scarring alopecia. The absolute risk is low, but awareness may inform treatment decisions. Rapid weight loss and hormonal changes are thought to be contributing factors.
A new review introduces a chronological and probabilistic model to explain the recurrence of autoimmune skin diseases like vitiligo. The model proposes that full disease manifestation is the outcome of genetic susceptibility and a series of environmental or internal biological hits.
A new study reveals that stevioside can effectively promote hair follicles to enter the growth phase when combined with minoxidil. The natural sweetener enhances skin absorption of the drug, leading to new hair development in a mouse model of alopecia.
A review by Prof. Mayer Brezis reveals finasteride's potential psychiatric effects, including depression and suicidal thoughts, despite mounting evidence; hundreds of thousands may have suffered from depression, and hundreds more may have died by suicide.
The study found that alopecia stigma affects over 80% of patients with anxiety or depression, while those with more positive perceptions have lower anxiety symptoms. The researchers hope to assess patients' illness perceptions and stigma in routine check-ups to provide targeted support.
Researchers found that lower doses (20mg) and higher doses (100mg) of doxycycline were equally effective in treating lymphocytic scarring alopecia, a rare skin condition causing permanent hair loss. The low-dose regimen resulted in fewer side effects and no compromise on efficacy or anti-inflammatory benefit.
Researchers from IOCB Prague have developed a compound that could treat alopecia areata by targeting the immune system. The substance, a series of prodrugs based on derivatives of itaconic acid, has shown efficacy in mice tests and may be administered orally.
Researchers found a rare genetic interaction between ERAP1 and ERAP2 genes that increases the risk of frontal fibrosing alopecia (FFA). The study sheds light on the autoimmune basis of FFA and may lead to new treatments, including predictive genetic tests.
A team of researchers from Penn State and the University of California, Irvine, have proposed a novel theory on the molecular basis underlying human scalp hair growth. They suggest that long scalp hair initially evolved to protect early human ancestors in equatorial Africa from intense heat and solar radiation.
Researchers found comorbidities like asthma and atopic dermatitis associated with earlier onset, severity, and duration of alopecia areata. AA patients with multiple concomitant diseases reported more severe hair loss.
A study suggests that low doses of the commonly prescribed hair loss treatment minoxidil are safe and effective for regrowing hair in most breast cancer patients. The researchers found that all participants who took a low dose of oral minoxidil saw improvements in hair growth or stabilization within three to six months.
A systematic review and meta-analysis found a slightly higher likelihood of androgenetic alopecia among individuals who consume alcohol, but the association is not statistically significant. The study suggests that further research is needed to clarify whether alcohol impacts AGA risk.
Researchers at the University Hospital Bonn identified a new gene, KRT31, responsible for dominantly-inherited monilethrix, a rare congenital form of hair loss. The discovery improves diagnosis and sheds light on the genetic mechanism underlying this condition.
A large-scale study investigated the relationship between childhood obesity and immune-mediated skin diseases (IMSDs), such as atopic dermatitis and psoriasis. The study found that obese children were more likely to develop these conditions, with changes in body weight affecting their risk of developing these diseases.
SourceElsevier·JournalJournal of Investigative Dermatology·TypeData/statistical analysis·DateAug 21, 2024
A clinical trial shows that JAK inhibitors improve autoimmune conditions such as alopecia areata, atopic dermatitis, and psoriasis in people with Down syndrome. The study also observed improvements in arthritis and decreased biomarkers of autoimmune thyroid disease.
A new microneedle patch has been developed to treat autoimmune disease alopecia areata by delivering immune regulators to affected skin areas, promoting lasting hair regrowth. The approach restores immune balance and resolves T cell attack on hair follicles, offering a potential long-term solution without compromising the immune system.
Researchers developed a microneedle patch that delivers immune-regulating molecules to the scalp, teaching T cells not to attack hair follicles and helping hair regrow. In mouse studies, this treatment reduced inflammation and allowed hair to regrow without systemic immune effects.
A new Northwestern Medicine study reveals that 73% of children with skin diseases face stigma and bullying, leading to impaired relationships and mental health issues such as depression and anxiety. The study suggests that clinicians should aggressively treat skin disorders in children and consider referral to evaluation and counseling.
Researchers at Yokohama National University found that cinnamic acid activates oxytocin receptor expression, increasing hair growth gene expression in human dermal papilla cells. The compound showed a similar hair growth effect to oxytocin, with a 1.25-fold increase in hair shaft-like structures.
Researchers discovered distinct mechanisms controlling different types of immune cells and found a way to selectively eliminate 'problematic' cells driving autoimmune disorders. This breakthrough offers precise targets for potential treatment strategies, potentially revolutionizing the way we treat skin conditions.
Researchers at Rensselaer Polytechnic Institute have successfully created hair follicles in human skin tissue using 3D-bioprinting techniques. This innovation has potential applications in regenerative medicine, drug testing, and understanding the complex interactions between skin and topical products.
A major European study found that almost all patients with skin diseases face embarrassment, leading to a huge psychological toll. The study also revealed that stigmatization is a major impact of skin diseases on personal and professional life.
SourceBeyond·JournalJournal of the European Academy of Dermatology and Venereology·DateOct 8, 2023
A recent study published in Nature Communications has identified five rare genetic variants associated with male-pattern hair loss. The researchers analyzed the genetic sequences of 72,469 male participants from the UK Biobank project and found associations between rare variants in genes such as EDA2R, WNT10A, HEPH, CEPT1, and EIF3F.
Researchers used AI to predict compounds that could neutralize reactive oxygen species causing baldness. They successfully regenerated hair on mice using microneedle patches, providing a promising new treatment for androgenic alopecia.
Researchers have identified a key chemical controlling hair follicle cell division and death, shedding light on a potential cure for baldness. The discovery also holds promise for speeding up wound healing by harnessing the regenerative properties of stem cells found in hair follicles.
Researchers at the University of California, Irvine have identified SCUBE3 as a potential therapeutic treatment for androgenetic alopecia. The study found that dermal papilla cells produce activating molecules to promote new growth, which are reduced in people with hair loss.
Researchers at the Salk Institute have identified an unexpected molecular target of a common treatment for alopecia, a condition where the immune system attacks hair follicles. They found that glucocorticoid hormones instruct regulatory T cells to activate hair follicle stem cells, leading to hair growth and regeneration.
Researchers developed a nanocomposite coating method using Langmuir-Blodgett technology to improve wig durability, reducing UV damage, breakage, and static electricity. The new coating provides better coverage than previous methods and can be scaled up for mass production.
A new study found that more than half of postmenopausal women suffer from female pattern hair loss, a condition characterized by gradual thinning at the part line. The study also discovered a significant association between obesity and worsening hair loss in postmenopausal women.
Common hair loss patterns in women include progressive ponytail thinning, increased scalp visibility, and easy sunburn. New therapies such as platelet-rich plasma injections offer promise for stimulating hair growth and minimizing thinning, while treatments like minoxidil and finasteride may also be effective.
A new microneedle patch containing cerium nanoparticles has been designed to combat both primary causes of baldness: oxidative stress and insufficient circulation. The patch showed faster hair regrowth in a mouse model compared to a leading treatment.
Researchers discovered a novel biomarker, AR CAG repeat length, which is associated with COVID-19 disease severity in men. A prospective study of 65 hospitalised COVID-19 positive men found that males with a CAG repeat below 22 nucleotides were significantly less likely to be admitted into ICU.
Researchers assessed stigma levels among people with varying degrees of hair loss, revealing a significant impact on mental health and self-perception. The study found that those with noticeable hair loss reported feelings of shame and low self-confidence, highlighting the need for increased awareness and support.
Analysis of 990 COVID-19 cases reveals a subset of 'long-haulers' with prolonged dermatological symptoms, including hives and 'COVID toes', persisting for weeks or months. The study highlights the need for further research into COVID-19's impact on skin conditions.
Researchers found that a protein called Rictor plays a key role in regulating stem cell metabolism, which can help prevent hair loss. The study used a genetic mouse model to demonstrate that the absence of Rictor protein impaired stem cell function and led to hair loss.
A retrospective study from George Washington University found that spironolactone is not associated with increased risk of female breast cancer recurrence. The drug may be used as an additional treatment option for alopecia in female breast cancer patients who are disease-free.
This observational study examines characteristics and response to treatment of persistent radiation-induced hair loss in patients with primary central nervous system tumors or head and neck cancer. The study aims to improve treatment outcomes for this common side effect.
A recent clinical trial has demonstrated the ability of a stem cell-based topical solution to regrow hair in individuals with androgenetic alopecia, also known as male-pattern baldness. The study found that the treatment led to significant increases in both hair count and follicle diameter.
Researchers at Massachusetts General Hospital developed a new method to examine the activity of human hair follicles using magnetic fields. The technique measures electrical activity in individual study subjects and has shown promise as a biomarker for treating hair loss conditions like alopecia.
Researchers have created a low-cost, noninvasive hair-growth-stimulating technology that uses gentle electric pulses to reactivate dormant follicles. The devices are powered by the wearer's day-to-day motion and show promise in stimulating hair growth with minimal side effects.
Scientists have found a way to protect hair follicles from chemotherapy, potentially preventing hair loss. Researchers used CDK4/6 inhibitors to halt cell division and reduce damage caused by taxanes, common anti-cancer drugs that can induce permanent hair loss.
Researchers at Yokohama National University developed an efficient method to generate hair growth in nude mice using a three-dimensional tissue culture called hair follicle germ. The new approach produces a high rate of hair generation and shows promise for clinical applications in human hair regenerative therapy.
Researchers have developed a method to generate natural-looking hair that grows through the skin using human induced pluripotent stem cells. This technology has the potential to treat hair loss in millions of people worldwide.
A recent study found a gene variant in the SGK3 gene causing hairlessness in Scottish Deerhounds. The defect results in puppies born with thin fur that loses all their hair in weeks. This discovery may also provide insights into human non-hormonal baldness, as the SGK3 gene is also associated with early hair loss and baldness.
Researchers have identified a new gene, LSS, responsible for hypotrichosis simplex, a rare form of hair loss. The gene's mutation impairs an enzyme crucial to cholesterol metabolism, leading to progressive hair loss from childhood on.
Researchers at Massachusetts General Hospital report significant hair regrowth in a 13-year-old patient with total alopecia and eczema after treatment with dupilumab. The drug's mechanism of targeting an immune system pathway overactive in eczema may also induce hair growth in other alopecia patients.
Researchers developed a flexible, wearable photostimulator that speeds up hair growth in mice, achieving significantly faster hair regrowth and wider regrowth areas compared to untreated or minoxidil-injected mice.
Researchers have successfully reversed hair loss and skin inflammation in mice fed a Western diet high in fat and cholesterol. The experimental compound D-PDMP halts the production of glycosphingolipids, which are major components of skin and cell membranes.
A gene mutation causes wrinkled skin and hair loss; turning off that mutation restores the mouse to normal appearance. The study reveals an important role for mitochondria in skin health, with reversed mitochondrial dysfunction leading to restored smooth skin and thick fur.
A study found that a drug originally designed to treat osteoporosis enhances human hair growth by inhibiting SFRP1, a key protein that regulates Wnt signalling. This new agent, WAY-316606, shows promise in promoting hair growth without the side effects of existing treatments.
Researchers discovered a novel mechanism of action for an immunosuppressive drug that promotes human hair growth and reduces hair loss. A compound targeting the same mechanism has shown similar effects in promoting hair growth without side effects.
Platelet-rich plasma (PRP) injection has shown positive aesthetic outcomes in facial rejuvenation, hair regrowth, and acne scar treatment. However, the research evidence is limited due to inconsistent PRP preparation and injection techniques, lack of standardized assessments, and short follow-up periods.
Researchers have developed a method for mass preparing cellular aggregates called 'hair follicle germs' that may lead to new treatment for hair loss. The therapy involves regenerating hair follicles, the tiny organs that grow and sustain hair, on a large scale.
Researchers analyzed medical records of 487,104 black women and found that those with CCCA had a significantly higher prevalence of uterine fibroids compared to controls. The findings suggest a possible link between the two conditions, warranting increased awareness among physicians and patients.
A study published by the European Society of Cardiology found that male-pattern baldness and premature greying are associated with a higher risk of coronary artery disease in young men. Obesity was also linked to an increased risk, but not to the same extent as these two factors.
Research published in the Journal of Epidemiology & Community Health found that heavy drinking and smoking are associated with visible signs of physical ageing. Light to moderate drinking was not linked to biological ageing or slowing down the visible ageing process.
A new study analyzes Google Trends data across eight countries, finding summer and fall seasons correlate with greater hair loss. The findings provide evidence for seasonality in hair loss at a population level, supporting future research into the physiology of the hair cycle.
Researchers linked lower levels of WNT10A protein to male pattern baldness and found a treatment mechanism involving beta-catenin signaling. Small molecule drugs targeting this pathway may treat hair thinning and palm skin defects in WNT10A patients.
Researchers analyzed top 10 film heroes and villains, finding six villains had facial skin issues, including alopecia and hyperpigmentation. The study suggests unfair portrayals of dermatologic conditions may contribute to prejudice and cultural misunderstandings.